MLICM
CLPT icon

Metropolitan Life Insurance Company (MetLife)’s ClearPoint Neuro CLPT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,270
Closed -$8.64K – 441
2024
Q1 		$8.64K Hold
1,270
– – ﹤0.01% 2178
2023
Q4 		$8.62K Hold
1,270
– – ﹤0.01% 2225
2023
Q3 		$6.36K Hold
1,270
– – ﹤0.01% 2373
2023
Q2 		$9.2K Buy
+1,270
New +$10.8K ﹤0.01% 2337
2021
Q4 		– Sell
-5,911
Closed -$105K – 2790
2021
Q3 		$105K Hold
5,911
– – ﹤0.01% 2493
2021
Q2 		$113K Buy
+5,911
New +$114K ﹤0.01% 2533

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CLPT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ClearPoint Neuro (CLPT) in Q2 2024, closing a stake of 1,270 shares — an estimated $8.64K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CLPT in Q2 2021 and held it in 6 quarters. The position peaked at $113K in Q2 2021. 86 funds tracked by Wall St. Rank hold CLPT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ClearPoint Neuro position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,270 ClearPoint Neuro shares in Q2 2024, an estimated $8.64K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ClearPoint Neuro in Q2 2021 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ClearPoint Neuro position peaked at $113K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.